Gariepy G, Nitka D, Schmitz N (2010) The association between obesity and anxiety disorders in the population: a systematic review and meta-analysis
Many patients are on a combination of an SGLT2 inhibitor with a GLP-1 receptor agonist or tirzepatide (a dual agonist) and have incredible success without adverse reactions, but we are still figuring out the patient characteristics that would put them at higher risk of poor outcomes. Eli J
Harshaw C, Warner AG
The associations were strongest for liver, lung, pancreatic cancers, and myeloid malignancies
COD is available on vials, oral products, and bacteriostatic water from your very first order
If youre using a GLP-1 as part of your plan, you can get support with side effects and tips on how to develop sustainable habits with our GLP-1 Companion Program